Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Intelligent Bio Solutions ( (INBS) ) has provided an update.
On July 15, 2025, Intelligent Bio Solutions Inc. announced the addition of the SmarTest® Patch to its non-invasive drug testing solutions portfolio. This innovative wearable device, developed by SMARTOX®, allows for continuous drug detection through sweat over a 7 to 10-day period. The SmarTest Patch complements the company’s existing Intelligent Fingerprinting Drug Testing Solution, enhancing its product offerings and market position in non-invasive testing technologies. The new device is expected to open opportunities in markets requiring longer detection windows, particularly in justice and rehabilitation settings, thereby strengthening the company’s position as demand for non-invasive drug testing options grows.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Neutral.
The overall score is supported by strong global expansion and technical indicators, despite financial challenges. The company’s efforts to improve profitability and expand internationally are positive, yet the valuation remains a concern due to negative earnings.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company specializing in intelligent, rapid, non-invasive testing solutions. The company offers the Intelligent Fingerprinting Drug Screening System, which utilizes fingerprint sweat analysis for drug detection, catering to industries such as construction, manufacturing, transport, and drug treatment organizations outside the US.
Average Trading Volume: 131,338
Technical Sentiment Signal: Sell
Current Market Cap: $12.23M
See more data about INBS stock on TipRanks’ Stock Analysis page.